Rhythm Pharmaceuticals Inc

11 de set. de 2026, 19:52 UTC

Rhythm Pharmaceuticals shares are higher during Friday's session, pulling back from earlier gains. No specific news was identified to explain the movement.

8 de set. de 2026, 20:08 UTC

RYTM trades lower as the biotech sector faces pressure.

2 de set. de 2026, 20:08 UTC

Rhythm Pharmaceuticals is higher today, supported by gains in the Biotechnology sector and CFO share transactions that reflect confidence in future performance.

1 de set. de 2026, 19:26 UTC

Rhythm Pharmaceuticals reported a net loss of -$33.26 million on revenue of $17.28 million. Shares are lower, continuing a trend of three consecutive sessions finishing down.

31 de ago. de 2026, 23:46 UTC

Rhythm Pharmaceuticals Inc shares rose in after-market trading, reflecting a gradual increase from earlier lows, though still below the 20-day moving average.

28 de ago. de 2026, 20:02 UTC

Rhythm Pharmaceuticals Inc shares are lower as Deutsche Bank initiates coverage with a Hold rating and a price target of $120.

26 de ago. de 2026, 20:08 UTC

Rhythm Pharmaceuticals is trading lower, influenced by declines in the Biotechnology sector and a broader market downturn since Tuesday's close.

25 de ago. de 2026, 21:02 UTC

Rhythm Pharmaceuticals Inc shares are lower in after-market hours. No specific news was identified to explain the decline, contrasting recent upward trends.

21 de ago. de 2026, 19:36 UTC

Rhythm Pharmaceuticals Inc shares are higher during Friday's session, reflecting positive market response. The stock reached a session high earlier before pulling back.

20 de ago. de 2026, 20:02 UTC

Rhythm Pharmaceuticals is lower today, influenced by a significant decline in the Biotechnology sector and high trading volume. The stock has dropped sharply since Wednesday.

13 de ago. de 2026, 19:51 UTC

Rhythm Pharmaceuticals is advancing amid broader market gains, supported by strong technology sector performance and high trading volume, despite no specific company news.

12 de ago. de 2026, 19:46 UTC

Rhythm Pharmaceuticals received expanded marketing authorization for IMCIVREE in the UK. Shares are trading higher since Tuesday's close, near the upper end of their one-month range.

11 de ago. de 2026, 19:36 UTC

Rhythm Pharmaceuticals received expanded UK approval for IMCIVREE to treat obesity, yet shares are declining amid broader market sentiment concerns.

10 de ago. de 2026, 19:31 UTC

Rhythm Pharmaceuticals Inc shares are lower today, retracing gains after an early drop. The stock is experiencing unusually high trading volume.

7 de ago. de 2026, 20:06 UTC

RYTM higher after JPMorgan raised price target to $146.00.

6 de ago. de 2026, 21:05 UTC

Rhythm Pharmaceuticals Inc shares are higher in after-market trading, reaching a high and remaining above the 20-day moving average. No specific news was identified.

5 de ago. de 2026, 20:02 UTC

Rhythm Pharmaceuticals shares rise as Citigroup, RBC, and Citizens raise price targets to $143, $155, and $160, respectively, reflecting growing confidence in the company.

4 de ago. de 2026, 20:13 UTC

Rhythm Pharmaceuticals shares are trading higher in after-market hours following CEO and CFO participation in upcoming investor conferences, enhancing visibility among stakeholders.

3 de ago. de 2026, 19:51 UTC

Rhythm Pharmaceuticals Inc shares are higher today amid unusually high trading volume, continuing the upward trend since Friday's close. No specific news was identified.

31 de jul. de 2026, 22:56 UTC

Rhythm Pharmaceuticals Inc shares are higher in after-market trading, despite earlier fluctuations and no specific news identified to explain the movement.

30 de jul. de 2026, 18:46 UTC

Rhythm Pharmaceuticals Inc shares are lower today, continuing a downward trend since Wednesday. No specific news has been identified to explain the decline.

29 de jul. de 2026, 18:46 UTC

Rhythm Pharmaceuticals Inc shares are lower today, influenced by rising oil prices amid escalating Middle East tensions, though no specific company news was identified.

28 de jul. de 2026, 19:11 UTC

Rhythm Pharmaceuticals Inc. shares are higher today, supported by strong trading volume and positive momentum in the biotechnology sector. No specific news was identified.

27 de jul. de 2026, 19:33 UTC

RYTM trades higher after JPMorgan's Overweight rating and $145 target.

24 de jul. de 2026, 21:01 UTC

Rhythm Pharmaceuticals Inc shares are higher in after-market trading, reflecting a positive shift since Friday's close despite broader market challenges.

21 de jul. de 2026, 14:36 UTC

Rhythm Pharmaceuticals will report second-quarter 2026 results on August 4, contributing to higher shares amid positive market sentiment and gains in the Nasdaq 100 Index.

20 de jul. de 2026, 20:51 UTC

Rhythm Pharmaceuticals Inc is lower in after-market trading, down significantly from Monday's close and below its 20-day moving average. No specific news was identified.